Skip to main content
REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.69
+0.07 (0.81%)
At close: Apr 28, 2026, 4:00 PM EDT
8.60
-0.09 (-1.04%)
Pre-market: Apr 29, 2026, 4:21 AM EDT

REGENXBIO Revenue

In the year 2025, REGENXBIO had annual revenue of $170.44M with 104.54% growth. REGENXBIO had revenue of $30.34M in the quarter ending December 31, 2025, with 43.00% growth.

Revenue (ttm)
$170.44M
Revenue Growth
+104.54%
P/S Ratio
2.63
Revenue / Employee
$459,410
Employees
371
Market Cap
448.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025170.44M87.11M104.54%
Dec 31, 202483.33M-6.91M-7.66%
Dec 31, 202390.24M-22.48M-19.94%
Dec 31, 2022112.72M-357.62M-76.03%
Dec 31, 2021470.35M315.78M204.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RGNX News

More News